Corinne Faivre-Finn π
@finn_corinne
French and European, Prof of Thoracic Radiation Oncology, Researcher, RCTs, phase 1 drug-RT, ePROM, RWE, NIHR Senior Investigator, mother of 2. Views are my own
ID: 2582454033
04-06-2014 13:54:29
4,4K Tweet
4,4K Followers
417 Following
Thrilled to participate on this all-star panel of amazing friends and leaders! I'll be joined by Rajika Jindani, MD, MPH, MS, a surgical resident at Montefiore Health System Albert Einstein College of Medicine - Official who I am grateful to sponsor & mentor, as we focus on supporting the Next Generation and the call to "Sponsor Her".
Fascinating field of research which we are aiming to implement in radiation oncology in Manchester ! πRTphysics Manchester Manchester Cancer Research Centre The Christie NHS
The Lung Team at the Christie is currently recruiting in studies for patients with stage 4 ROS1+ NSCLC who have received at least one previous line of treatment. If interested, please email [email protected] BTOG The ROS1ders, Inc.
π Applications open for BONUS National #Oncology #Mentorship Scheme 2024/2025. Whether you're a med student or junior doctor, this is your chance to be paired with #oncologists across the UK for 6 months. More info bonus-oncology.co.uk/post/national-β¦ Deadline: 22 Sep 2024, 11:59 PM
Looking forward to your #WCLC24 presentation Joe Y Chang
Nice paper Sarah βΆοΈ 'Beyond mean heart dose' βΆοΈprovides a summary of existing evidence of dose limits to β€οΈ substructues βΆοΈexplains how dose limits vary according to different sites/RT techniques βΆοΈproposes plan optimisation solutions RTphysics Manchester pubmed.ncbi.nlm.nih.gov/39228181/
An apt title for this lecture by Professor McNair H A McNair π. A fantastic turnout for this celebration from family, friends, colleagues and so many more. Standing ovation at the end for the well deserved prof. ππ»
T-1.5 days until IASLC #WCLC24 And here are your Social Media Ambassadors- the IASLC communications committeeπ Follow these folks to track the best in thoracic onc in San DiegoβοΈ Matthew Smeltzer Stephen V Liu, MD Charu Aggarwal, MD, MPH, FASCO Aakash Desai, MD, MPH Dusty Joy Donaldson Narjust Florez, MD, FASCO RadOncResearch
At The Christie NHS we have already moved beyond heart dose β‘οΈ dose limit to base of heart implemented in the routine setting in stage 1-3 NSCLC β‘οΈimpact on survival/toxicity evaluated using rapid-learning methodology RTphysics Manchester clinicaloncologyonline.net/article/S0936-β¦
Great session Brendon Stiles So sorry to miss it as my flight will arrive too late #WCLC24
Excellent session highlighting that the UK is leading the way in early-phase trials combining drug-radiotherapy A standout example is the CONCORDE trial β‘οΈPlatform trial incorporating multiple DDR inhibitors β‘οΈTITE-CRM Bayesian design β‘οΈRandomised controlled arm Leeds CTRU Cancer Research UK
Congratulations Gerard Walls ππ